These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9859692)

  • 1. [Safety profile of 311C90 (zolmitriptan)].
    Morales Asín F
    Neurologia; 1998 Oct; 13 Suppl 2():25-30. PubMed ID: 9859692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.
    Edmeads JG; Millson DS
    Cephalalgia; 1997 Oct; 17 Suppl 18():41-52. PubMed ID: 9399016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolmitriptan.
    Can Fam Physician; 1999 Jun; 45():1491-4, 1497-501. PubMed ID: 10386213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
    Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolmitriptan: a review of its use in migraine.
    Spencer CM; Gunasekara NS; Hills C
    Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
    Peck RW; Seaber EJ; Dixon RM; Layton GR; Weatherley BC; Jackson SH; Rolan PE; Posner J
    Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of zolmitriptan in migraine].
    Leira R; Noya M
    Neurologia; 1998 Oct; 13 Suppl 2():16-24. PubMed ID: 9859691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolmitriptan for migraine.
    Med Lett Drugs Ther; 1998 Feb; 40(1021):27-8. PubMed ID: 9505961
    [No Abstract]   [Full Text] [Related]  

  • 12. Zolmitriptan: new product. Similar to sumatriptan.
    Prescrire Int; 1999 Apr; 8(40):41-3. PubMed ID: 10848058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
    Rolan P
    Cephalalgia; 1997 Oct; 17 Suppl 18():21-7. PubMed ID: 9399014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolmitriptan provides effective migraine relief in adolescents.
    Linder SL; Dowson AJ
    Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan.
    Peterlin BL; Rapoport AM
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):899-911. PubMed ID: 18028032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of zolmitriptan].
    Pascual J
    Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy.
    Schoenen J; Sawyer J
    Cephalalgia; 1997 Oct; 17 Suppl 18():28-40. PubMed ID: 9399015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.